The prognostic role of cancer stem cells in breast cancer: A meta-analysis of published literatures

Breast Cancer Research and Treatment

Volumn 122, Issue 3, 2010, Pages 795-801

  Zhou, Liheng ^a,b   Jiang, Yiwei ^a,b   Yan, Tingting ^a,b   Di, Genhong ^a,b   Shen, Zhenzhou ^a,b   Shao, Zhimin ^a,b   Lu, Jinsong ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

ALDH1; Breast cancer; Breast cancer stem cells; CD44+ CD24 low

Indexed keywords

ALDEHYDE DEHYDROGENASE; CD24 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HERMES ANTIGEN; ALDEHYDE DEHYDROGENASE ISOENZYME 1; ISOENZYME; PROGESTERONE RECEPTOR; RETINAL DEHYDROGENASE; TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER STEM CELL; CANCER SURVIVAL; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME; BLOOD; BREAST NEOPLASMS; FEMALE; META ANALYSIS; METABOLISM; PATHOLOGY;

ALDEHYDE DEHYDROGENASE; BREAST NEOPLASMS; FEMALE; HUMANS; ISOENZYMES; NEOPLASTIC STEM CELLS; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL; RETINAL DEHYDROGENASE;

EID: 77955552069     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0999-4     Document Type: Article

References (24)

1. T Reya SJ Morrison MF Clarke IL Weissman 2001 Stem cells, cancer, and cancer stem cells Nature 414 105 111 10.1038/35102167 1:CAS:528: DC%2BD3MXot1ahs7c%3D 11689955 (Pubitemid 33041634)
2. G Dontu S Liu MS Wicha 2005 Stem cells in mammary development and carcinogenesis: implications for prevention and treatment Stem Cell Rev 1 207 213 10.1385/SCR:1:3:207 1:CAS:528:DC%2BD28XhtVOjt78%3D 17142857 (Pubitemid 41737097)
3. JC Lawson GL Blatch AL Edkins 2009 Cancer stem cells in breast cancer and metastasis Breast Cancer Res Treat 118 241 254 10.1007/s10549-009-0524-9 19731012
4. M Al-Hajj MS Wicha A Benito-Hernandez SJ Morrison MF Clarke 2003 Prospective identification of tumorigenic breast cancer cells Proc Natl Acad Sci USA 100 3983 3988 10.1073/pnas.0530291100 1:CAS:528:DC%2BD3sXivFSqtbs%3D 12629218 (Pubitemid 36418143)
5. C Sheridan H Kishimoto RK Fuchs S Mehrotra P Bhat-Nakshatri CH Turner R Goulet Jr S Badve H Nakshatri 2006 CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis Breast Cancer Res 8 R59 10.1186/bcr1610 17062128 (Pubitemid 44804002)
6. TM Phillips WH McBride F Pajonk 2006 The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation J Natl Cancer Inst 98 1777 1785 10.1093/jnci/djj495 17179479 (Pubitemid 46017929)
7. C Ginestier MH Hur E Charafe-Jauffret, et al. 2007 ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Cell Stem Cell 1 555 567 10.1016/j.stem.2007.08.014 1:CAS:528: DC%2BD2sXhsVahtrvF 18371393 (Pubitemid 350056407)
8. BK Abraham P Fritz M McClellan P Hauptvogel M Athelogou H Brauch 2005 Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis Clin Cancer Res 11 1154 1159 1:CAS:528:DC%2BD2MXht1ynt7k%3D 15709183
9. Resetkova, E, Reis-Filho JS, Jain RK, Mehta R, Thorat MA, Nakshatri H, Badve S (2009) Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment. Breast Cancer Res Treat. doi: 10.1007/s10549-009-0619-3
10. G Dontu 2008 Breast cancer stem cell markers-the rocky road to clinical applications Breast Cancer Res 10 110 10.1186/bcr2130 18828879
11. MK Parmar V Torri L Stewart 1998 Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints Stat Med 17 2815 2834 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0. CO;2-8 1:STN:280:DyaK1M7itVWksA%3D%3D 9921604 (Pubitemid 28562978)
12. H Nalwoga JB Arnes H Wabinga LA Akslen 2010 Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer Br J Cancer 102 369 375 10.1038/sj.bjc.6605488 1:CAS:528:DC%2BC3cXntlKisA%3D%3D 20010944
13. K Morimoto SJ Kim T Tanei K Shimazu Y Tanji T Taguchi Y Tamaki N Terada S Noguchi 2009 Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression Cancer Sci 100 1062 1068 10.1111/j.1349-7006.2009.01151.x 1:CAS:528:DC%2BD1MXntlSjtLg%3D 19385968
14. V Neumeister S Agarwal J Bordeaux RL Camp DL Rimm 2010 In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis Am J Pathol 176 5 2131 2138 10.2353/ajpath.2010.090712 1:CAS:528:DC%2BC3cXmvFSqsb0%3D 20228222
15. E Charafe-Jauffret C Ginestier F Iovino, et al. 2010 Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer Clin Cancer Res 16 45 55 10.1158/1078-0432.CCR-09-1630 1:CAS:528:DC%2BC3cXot1Wh 20028757
16. G Honeth PO Bendahl M Ringner, et al. 2008 The CD44+/CD24- phenotype is enriched in basal-like breast tumors Breast Cancer Res 10 R53 10.1186/bcr2108 18559090
17. R Liu X Wang GY Chen, et al. 2007 The prognostic role of a gene signature from tumorigenic breast-cancer cells N Engl J Med 356 217 226 10.1056/NEJMoa063994 1:CAS:528:DC%2BD2sXns12mug%3D%3D 17229949 (Pubitemid 46143225)
18. M Buess M Rajski BM Vogel-Durrer R Herrmann C Rochlitz 2009 Tumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancer Neoplasia 11 987 1002 1:CAS:528:DC%2BD1MXhtFKrsLfJ 19794958
19. JI Herschkowitz K Simin VJ Weigman, et al. 2007 Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors Genome Biol 8 R76 10.1186/gb-2007-8-5-r76 17493263 (Pubitemid 351902765)
20. CJ Creighton X Li M Landis, et al. 2009 Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features Proc Natl Acad Sci USA 106 13820 13825 10.1073/pnas.0905718106 1:CAS:528:DC%2BD1MXhtFWksLjF 19666588
21. AK Croker D Goodale J Chu C Postenka BD Hedley DA Hess AL Allan 2009 High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability J Cell Mol Med 13 2236 2252 10.1111/j.1582-4934.2008.00455.x 18681906
22. T Tanei K Morimoto K Shimazu SJ Kim Y Tanji T Taguchi Y Tamaki S Noguchi 2009 Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential paclitaxel and epirubicin-based chemotherapy for breast cancers Clin Cancer Res 15 4234 4241 10.1158/1078-0432.CCR-08-1479 1:CAS:528:DC%2BD1MXntlOitrw%3D 19509181
23. S Aulmann N Waldburger R Penzel M Andrulis P Schirmacher HP Sinn 2010 Reduction of CD44(+)/CD24(-) breast cancer cells by conventional cytotoxic chemotherapy Hum Pathol 41 574 581 10.1016/j.humpath.2009.08.023 1:CAS:528:DC%2BC3cXjtFyiurY%3D 20004947
24. E Mylona I Giannopoulou E Fasomytakis A Nomikos C Magkou P Bakarakos L Nakopoulou 2008 The clinicopathologic and prognostic significance of CD44+/CD24(-/low) and CD44-/CD24+ tumor cells in invasive breast carcinomas Hum Pathol 39 1096 1102 10.1016/j.humpath.2007.12.003 1:CAS:528:DC%2BD1cXnsF2qu7g%3D 18495204